December 2024

Data showcased at SABCS and ASH reflect progress and growth of Jazz’s research and development in oncology and demonstrate ongoing efforts to redefine what is possible for cancer treatment DUBLIN, Dec. 3, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that th

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: